Previous studies have indicated Lrrc46 was found as a novel candidate susceptibility gene in familial prostate cancer (PCa) [66], high-grade serous ovarian cancer (HGSOC) [67,68], Glioblastoma [69], and Nasopharyngeal carcinoma (NPC) [70]. The gene discussed is LRRC46; the disease is posterior cortical atrophy.